Pathology
Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections
CerTest Biotec (Zaragoza, Spain; www.certest.es) has joined the fight against multidrug resistant strains (MDR) bacterial infections by developing real-time PCR assays for the fast detection of genes or punctual mutations that confer resistance to antibiotics from both Gram-positive and Gram-negative pathogens. More...23 Sep 2021
Blood Testing Distinguishes Benign Tumors from Precancerous Condition
The leading cause of mortality for patients with the neurofibromatosis type 1 (NF1) cancer predisposition syndrome is the development of malignant peripheral nerve sheath tumor (MPNST), an aggressive soft tissue sarcoma. In the setting of NF1, this cancer type frequently arises from within its common and benign precursor, plexiform neurofibroma (PN). More...15 Sep 2021
CCN1 Analyzed as a Biomarker for Breast Cancer Detection
Breast cancer is the most frequent malignancy in women with 1.7 million new cases and over 500,000 deaths worldwide in 2016. Early detection of cancer is believed to be crucial in reducing cancer death. Despite recent progress in liquid biopsy technologies, early blood-based detection of breast cancer is still a challenge. More...14 Sep 2021
Liquid Biopsy Assay Evaluated for Early Detection of Gastric Cancer
Gastric cancer (GC) is the fourth most-commonly diagnosed cancer, and the third leading cause of cancer-associated mortality worldwide. Despite improvements in treatment modalities, the prognosis for advanced GC following curative resection remains poor. More...08 Sep 2021
PD-L1 Expression in Circulating Tumor Cells Investigated for NSCLC
In non-small cell lung cancer (NSCLC), analysis of programmed cell death ligand 1 (PD-L1) expression in circulating tumor cells (CTCs) is a potential alternative to overcome the problems linked to the tumor biopsy spatiotemporal heterogeneity. However, the prognostic significance of PD-L1-positive [PD-L1(+)] CTCs remains controversial. More...07 Sep 2021
World's First AI-Powered Solution for Gastrointestinal Cancer Diagnostics to Help Pathologists Reduce Turnaround Time
The world's first Artificial Intelligence (AI)-powered solution for gastrointestinal (GI) cancer diagnostics is helping pathologists improve accuracy and efficiency of GI cancer diagnosis in routine practice. More...05 Sep 2021
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
HPV Test
Allplex HPV28 Detection
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
In Other News
NanoVelcro Cell Technology Applied in Diagnosis of Pregnancy Complications
Exhaled Nitric Oxide and Eosinophil Count Diagnose Eosinophilic Asthma
Leptomeningeal Disease Diagnosed Using CSF Cell-Free DNA
Biomarker p-120 Catenin Distinguishes Conventional Urothelial Carcinoma from Variants
Novel Blood-Based Test Bolsters MRI-Based Prostate Cancer Screening
Key Factors Signal Infection Risk in Alcoholic Hepatitis
Genomes of Advanced Neuroendocrine Neoplasms Unveil Subtypes
Multitarget Fecal Immunochemical Test Validated for Colorectal Cancer
CSF Conversion Assay Identifies Lewy Body Disease Cognitive Impairment
Minimal Residual Disease Test Predicts Oligometastatic CRC Patient Outcomes
Diagnostic Biomarker MMP-13 Explored for Cutaneous Squamous Cell Carcinoma
Immunoassays Compared for Serum HE4 Estimation for Ovarian Cancer
Preemies' Blood Type Tied to Risk for Necrotizing Enterocolitis
Telomerase Reverse Transcriptase Protein Expression Evaluated for Melanomas
Electronic Nose Sensor Accurately Detects Ovarian, Pancreatic Cancers
Protein Biomarker Helps Diagnose Pancreatic Cancer
Biomarkers Diagnose and Predict Acute Pancreatitis
Respiratory Syncytial Virus Bronchiolitis Has Different Subtypes
Hyperglycemia Evaluated as a Risk Factor in Pancreatic Cancer
Genetic Variants Associated with Unexplained Sudden Cardiac Death
CtDNA Analysis Assesses Early Relapse Detection in Colorectal Cancer
Liquid Biopsies Detect Pediatric Bone Tumors Based on Epigenetic Profiles
Genomic Differences Cause Racial Disparities in Prostate Cancer
The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
